Pinto Joshua
SEC insider (Form 3/4/5 filer). CIK 0001992595. President & CEO at Neumora Therapeutics, Inc. (NMRA) and 1 other issuer. 38 reported Form 4/5 transactions since Sep 2024; latest on Aug 20, 2026. Located in WATERTOWN, MA.
Companies Pinto Joshua has filed insider reports for
- Neumora Therapeutics, Inc. (NMRA): Director, Officer, President & CEO
- Metsera, Inc. (MTSR): Director
Pinto Joshua
CIK: 0001992595
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (38 total)
- Aug 20, 2026NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
500K shares- - Feb 17, 2026NMRA
Neumora Therapeutics, Inc.
SaleDirect6K shares at avg. $3.54$21K - Jan 8, 2026NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
1.2M shares- - Nov 13, 2025MTSR
Metsera, Inc.
AwardDirectRestricted Stock Unit
2.7K shares- - Nov 13, 2025MTSR
Metsera, Inc.
DispositionDirect2.7K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
270.8K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
223K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
127.4K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
223K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
720.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 20, 2026 |  NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| Feb 17, 2026 | NMRA Neumora Therapeutics, Inc. | Sale | 5,967 | $3.54 | $21,093 | Direct |
| Jan 8, 2026 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 1,200,000 | - | - | Direct |
| Nov 13, 2025 |  MTSR Metsera, Inc. | Award Restricted Stock Unit | 2,688 | - | - | Direct |
| Nov 13, 2025 | MTSR Metsera, Inc. | Disposition | 2,688 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 270,828 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 223,034 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 127,448 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 223,034 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 720,084 | - | - | Direct |
1-10 of 38 transactions